Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE000000735

Price
14.41 CNY
Market cap
13.93 bn CNY
P/E (2025)
406.20
P/S (2025)
11.90
Dividend yield
0.00 %
Net margin
2.93 %
Return on equity (ROE)
1.48 %
Return on assets (ROA)
0.77 %

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd financials

Fiscal year20242025
Revenue1.32 bn CNY1.17 bn CNY
Gross profit993.53 m CNY843.92 m CNY
Operating income67.43 m CNY121.16 m CNY
EBIT140.39 m CNY124.60 m CNY
Net income56.44 m CNY34.29 m CNY
Diluted EPS – continuing operations0.06 CNY0.04 CNY

Full history since 1994, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Tonghua Golden-Horse Pharmaceutical Industry Co Ltd

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. The company provides anti-tumor drugs, gynecological medications, medication for rheumatic bone pain, urological medications, heat-clearing and detoxifying drugs, cardiovascular and cerebrovascular drugs, digestive medications, tonifying and restorative medicines, respiratory medication, diabetes medication, ENT medication, and pediatric medications. It also offers Xiaojin pills, Tian Ranshexiang Xiaojin pills, Xiaokechuan capsules, Jiuwei Qianghuo granules, Xiongdan powder, Bear Bile powder, and Wenweishu tablets to treat glandular hyperplasia, inflammatory diseases, bone trauma and soft tissue injury, and other related diseases. In addition, the company provides bacillus cereus live bacteria capsules, bacillus cereus live bacteria tablets are therapeutic live bacteria microecological preparations to treat enteritis, diarrhea, infantile diarrhea, and intestinal dysfunction. The company was founded in 1990 and is headquartered in Tonghua, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.